Canada markets close in 4 hours 10 minutes

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.15+0.35 (+1.41%)
As of 11:50AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
360,911
377,709
60,920
51,844
24
-
Operating Expenses
Research Development
422,553
437,381
311,594
387,087
103,179
-
Selling General and Administrative
120,047
116,813
87,805
57,222
29,605
-
Total Operating Expenses
542,600
554,194
399,399
444,309
132,784
-
Operating Income or Loss
-181,689
-176,485
-338,479
-392,465
-132,760
-
Interest Expense
-
-
-
-
-
187
Total Other Income/Expenses Net
-245
-1,352
63,004
21,836
-62,883
-
Income Before Tax
-133,370
-131,161
-260,178
-370,638
-194,592
-
Income Tax Expense
-
1,366
3,410
0
0
-
Income from Continuing Operations
-134,736
-132,527
-289,088
-370,638
-194,592
-
Net Income
-134,736
-132,527
-289,088
-370,638
-194,592
-
Net Income available to common shareholders
-134,736
-132,527
-289,088
-370,638
-195,869
-
Basic EPS
-4.17
-1.72
-4.13
-5.77
-4.19
-
Diluted EPS
-4.17
-1.72
-4.13
-5.77
-4.19
-
Basic Average Shares
74,623
77,152
70,015
64,228
46,733
-
Diluted Average Shares
74,623
77,152
70,015
64,228
46,733
-